Article Information
vol. 5 no. 1
PubMed
Published By
Online ISSN
History
- Received October 30, 2018
- Accepted December 19, 2018
- Published online February 25, 2019.
Copyright & Usage
Copyright ©ERS 2019 This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
Author Information
- Jørgen Vestbo1,2⇑,
- Mark Dransfield3,
- Julie A. Anderson4,
- Robert D. Brook5,
- Peter M.A. Calverley6,
- Bartolome R. Celli7,
- Nicholas J. Cowans8,
- Courtney Crim9,
- Fernando Martinez5,10,
- David E. Newby11,
- Julie Yates9 and
- Peter Lange12,13
- on behalf of the SUMMIT Investigators
- 1Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK
- 2North West Lung Centre, Manchester University NHS Foundation Trust, Manchester, UK
- 3Lung Health Center, University of Alabama at Birmingham, Birmingham, AL, USA
- 4Research and Development, GlaxoSmithKline, Uxbridge, UK
- 5University of Michigan Health System, Ann Arbor, MI, USA
- 6University of Liverpool, Dept of Medicine, Clinical Sciences Centre, University Hospital Aintree, Liverpool, UK
- 7Pulmonary and Critical Care Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
- 8Veramed Ltd, Twickenham, UK
- 9Research and Development, GlaxoSmithKline, Research Triangle Park, NC, USA
- 10Division of Pulmonary and Critical Care Medicine, Weill Cornell Medicine, New York, NY, USA
- 11British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
- 12Dept of Public Health, Section of Social Medicine, University of Copenhagen, Copenhagen, Denmark
- 13Medical Unit, Respiratory Section, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark
- Jørgen Vestbo, 2nd Floor, ERC Building, Wythenshawe Hospital, Southmoor Road, Manchester, M23 9LT, UK. E-mail: jorgen.vestbo{at}manchester.ac.uk
Funding
GlaxoSmithKline
Article usage
Altmetrics
Vol 5 Issue 1
Table of Contents
Impact of pre-enrolment medication use on clinical outcomes in SUMMIT
